Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
30.71B | 28.26B | 27.56B | 21.17B | 18.61B | 13.98B | Gross Profit |
15.98B | 14.49B | 14.14B | 10.70B | 9.81B | 6.80B | EBIT |
10.37B | 9.02B | 9.04B | 6.50B | 6.75B | 4.05B | EBITDA |
11.50B | 10.12B | 9.98B | 7.10B | 7.23B | 4.55B | Net Income Common Stockholders |
8.70B | 7.57B | 7.84B | 5.62B | 5.88B | 3.55B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
9.10B | 12.74B | 7.01B | 7.38B | 7.59B | 7.35B | Total Assets |
45.48B | 48.59B | 39.96B | 38.83B | 30.23B | 27.27B | Total Debt |
3.68B | 3.68B | 4.86B | 4.26B | 4.08B | 4.66B | Net Debt |
-5.42B | -9.06B | -2.15B | -3.01B | -2.88B | -1.39B | Total Liabilities |
27.98B | 30.11B | 26.51B | 27.54B | 20.09B | 13.40B | Stockholders Equity |
17.50B | 18.48B | 13.45B | 11.29B | 10.14B | 13.87B |
Cash Flow | Free Cash Flow | ||||
9.29B | 9.10B | 3.25B | 7.22B | 9.91B | 3.63B | Operating Cash Flow |
11.36B | 11.17B | 5.44B | 9.43B | 10.85B | 4.63B | Investing Cash Flow |
-2.30B | -2.61B | -2.69B | -1.92B | -72.00M | -1.35B | Financing Cash Flow |
-5.06B | -2.83B | -3.00B | -7.19B | -9.89B | -753.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | €252.91B | 29.76 | 55.62% | 0.98% | 17.67% | 22.62% | |
77 Outperform | €23.70B | 49.47 | 13.66% | 0.62% | 22.22% | -10.98% | |
68 Neutral | €8.71B | 48.92 | 36.13% | 2.01% | 2.29% | -1.00% | |
62 Neutral | $11.75B | 10.58 | -7.10% | 2.91% | 7.47% | -7.95% |